Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in

Andrea Rognoni1, Fabrizio D'Ascenzo2, Martina Solli1

  • 1Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy.

Insights

Myocardial infarction (MI) admissions increased post-lockdown in Italy, particularly in the initial weeks. However, ST-segment elevation MI (STEMI) hospitalizations remained reduced, indicating a complex recovery pattern.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic led to decreased hospital admissions for myocardial infarction (MI).
  • The temporal trends and recovery patterns of MI admissions post-lockdown remain under-investigated.

Purpose of the Study:

  • To analyze the incidence rates (IRs) of acute MI admissions in Italy following the national COVID-19 lockdown.
  • To compare MI admission rates during the post-lockdown period with pre-lockdown, intra-lockdown, and inter-year control periods.

Main Methods:

  • Retrospective analysis of 2415 patients admitted for acute MI across nine Italian centers.
  • Comparison of MI incidence rates (IRs) between the post-lockdown period (May 4-July 12, 2020) and control periods (pre-lockdown, intra-lockdown, inter-year non-COVID-19).

Main Results:

  • MI admissions increased significantly post-lockdown compared to the intra-lockdown period (IRR: 1.60).
  • Post-lockdown MI admissions were lower than pre-lockdown (IRR: 0.86) but similar to the previous year (IRR: 0.96).
  • The increase in MI admissions was more pronounced in early post-lockdown weeks and significant for non-ST-segment elevation MI, but not for ST-segment elevation MI (STEMI), which saw reduced hospitalizations (IRR: 0.76).

Conclusions:

  • This study is the first to report an increase in MI admissions after Italy's national COVID-19 lockdown.
  • The rise in MI admissions was concentrated in the initial weeks post-lockdown.
  • ST-segment elevation MI (STEMI) hospitalizations did not recover to pre-pandemic levels, suggesting persistent impacts of the pandemic on acute cardiac care.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
86
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
59
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
255
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
119
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
78
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
142